Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-14 · accession 0001883850-22-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-03-15 | 2022-01-04 | REGN | VAGELOS P ROY | Dir | G - Gift | $0.00 | -338 | 141.3K | -0.2% | $0 |
| D | 2022-03-15 | 2022-03-14 | REGN | VAGELOS P ROY | Dir | M - OptEx | $179.13 | +75.0K | 393.7K | +24% | +$13.43M |
| D | 2022-03-15 | 2022-03-14 | REGN | VAGELOS P ROY | Dir | F - Tax | $655.29 | -48.1K | 345.6K | -12% | -$31.52M |
| D | 2022-03-15 | 2022-03-14 | REGN | VAGELOS P ROY | Dir | M - OptEx | $0.00 | -75.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-04 | G | D | 338 | $0.00 | 141,292 | I | — | — | |
| 2 | Common | Common Stock | 2022-03-14 | M | A | 75,000 | $179.13 | 393,669 | D by CLAT | — | — | |
| 3 | Common | Common Stock | 2022-03-14 | F | D | 48,103 | $655.29 | 345,566 | D | — | — | |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-03-14 | M | D | 75,000 | $0.00 | 0 | D | $179.13 · — to 2022-12-14 | 75,000 Common Stock | (F2) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |